MA26841A1 - Composes pour traiter les maladies pulmonaires - Google Patents

Composes pour traiter les maladies pulmonaires

Info

Publication number
MA26841A1
MA26841A1 MA26621A MA26621A MA26841A1 MA 26841 A1 MA26841 A1 MA 26841A1 MA 26621 A MA26621 A MA 26621A MA 26621 A MA26621 A MA 26621A MA 26841 A1 MA26841 A1 MA 26841A1
Authority
MA
Morocco
Prior art keywords
compounds
lung diseases
treating lung
treating
diseases
Prior art date
Application number
MA26621A
Other languages
English (en)
French (fr)
Inventor
Richard Nieman
Peter N Goodfellow
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MA26841A1 publication Critical patent/MA26841A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA26621A 1999-11-02 2002-05-02 Composes pour traiter les maladies pulmonaires MA26841A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
MA26841A1 true MA26841A1 (fr) 2004-12-20

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26621A MA26841A1 (fr) 1999-11-02 2002-05-02 Composes pour traiter les maladies pulmonaires

Country Status (29)

Country Link
EP (1) EP1225866A4 (bg)
JP (1) JP2003513028A (bg)
KR (1) KR20020057988A (bg)
CN (1) CN1387404A (bg)
AP (1) AP2002002496A0 (bg)
AR (1) AR029189A1 (bg)
AU (1) AU1357501A (bg)
BG (1) BG106748A (bg)
BR (1) BR0015270A (bg)
CA (1) CA2388333A1 (bg)
CO (1) CO5261512A1 (bg)
CZ (1) CZ20021512A3 (bg)
DZ (1) DZ3225A1 (bg)
EA (1) EA200200518A1 (bg)
EC (1) ECSP003747A (bg)
HK (1) HK1049107A1 (bg)
HU (1) HUP0203152A3 (bg)
IL (1) IL149367A0 (bg)
MA (1) MA26841A1 (bg)
MX (1) MXPA02004350A (bg)
NO (1) NO20022057L (bg)
OA (1) OA12076A (bg)
PE (1) PE20011005A1 (bg)
PL (1) PL355261A1 (bg)
SK (1) SK7592002A3 (bg)
TR (1) TR200201211T2 (bg)
TW (1) TWI242431B (bg)
WO (1) WO2001032127A2 (bg)
ZA (1) ZA200203435B (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU229442B1 (hu) * 2001-09-19 2013-12-30 Takeda Gmbh Nem-szteroid gyulladásgátlók és PDE4 inhibitorok kombinációi és alkalmazásuk
EP1463509A1 (en) * 2001-10-31 2004-10-06 MERCK PATENT GmbH Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
US20060199789A1 (en) * 2003-03-31 2006-09-07 Kyowa Hakko Kogyo Co., Ltd. medical composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
WO2006041121A1 (ja) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. 慢性皮膚疾患の治療および／または予防剤
RU2008119322A (ru) * 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Композиции ингибиторов фосфодиэстеразы iv типа
EP3431128A1 (en) 2010-01-05 2019-01-23 MicroDose Therapeutx, Inc. Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0710109T1 (en) * 1993-06-18 2005-02-28 Smithkline Beecham Corporation Method for identifying a PDE IV inhibitor
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
HUP0203152A2 (hu) 2003-01-28
DZ3225A1 (fr) 2001-05-10
NO20022057L (no) 2002-06-27
EP1225866A2 (en) 2002-07-31
HK1049107A1 (zh) 2003-05-02
MXPA02004350A (es) 2002-11-07
CO5261512A1 (es) 2003-03-31
EA200200518A1 (ru) 2002-10-31
CN1387404A (zh) 2002-12-25
KR20020057988A (ko) 2002-07-12
BR0015270A (pt) 2002-06-18
TR200201211T2 (tr) 2002-08-21
WO2001032127A2 (en) 2001-05-10
PL355261A1 (en) 2004-04-05
AU1357501A (en) 2001-05-14
PE20011005A1 (es) 2001-09-28
OA12076A (en) 2006-05-04
SK7592002A3 (en) 2002-11-06
BG106748A (bg) 2003-02-28
IL149367A0 (en) 2002-11-10
TWI242431B (en) 2005-11-01
NO20022057D0 (no) 2002-04-30
JP2003513028A (ja) 2003-04-08
CA2388333A1 (en) 2001-05-10
AP2002002496A0 (en) 2002-06-30
ZA200203435B (en) 2003-06-25
AR029189A1 (es) 2003-06-18
ECSP003747A (es) 2002-05-23
CZ20021512A3 (cs) 2003-04-16
WO2001032127A3 (en) 2001-12-06
EP1225866A4 (en) 2004-04-21
HUP0203152A3 (en) 2004-06-28

Similar Documents

Publication Publication Date Title
IL141335A0 (en) Therapies for treating pulmonary diseases
FI20000564A (fi) Menetelmä nanolaminaattien valmistamiseksi
IL147108A0 (en) Substituted heterocycle fused gamma-carbolines
HUP0200994A3 (en) Remedies for immunological diseases
IL150742A0 (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
IS5760A (is) Meðferðarlegar bíarýl afleiður
FR2770408B1 (fr) Poignee pour catheter
MA26841A1 (fr) Composes pour traiter les maladies pulmonaires
FR2818979B1 (fr) Procede de preparation d'imidaclopride
IL140326A0 (en) Protein c derivatives
GB9808665D0 (en) Therapeutic compounds
NO20012226D0 (no) Terapeutiske midler for medikamentavhengighet
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
GB2356362A9 (en) Ultrasonic nebuliser
GB9824897D0 (en) Therapeutic compounds
IL129273A0 (en) Antibodies to placental protein 13
FR2805535B1 (fr) Nouveau procede de preparation de l'isoindoline
GB0028484D0 (en) Imidazolone derivatives for the treatment of viral diseases
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
EP1097717A4 (en) MEDICINE FOR APOPTOSIS ASSOCIATED DISEASES
GB9808667D0 (en) Therapeutic compounds
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
GB9927698D0 (en) Therapeutic antibody
TH34294B (th) กระบวนการสำหรับการเตรียมคลอโรเบบโซซาโซล
SI1200447T1 (en) Oxazinocarbazoles for the treatment of cns diseases